H

HUTCHMED (China) Ltd
LSE:HCM

Watchlist Manager
HUTCHMED (China) Ltd
LSE:HCM
Watchlist
Price: 193 GBX -2.53%
Market Cap: 1.6B GBX

Wall Street
Price Targets

HCM Price Targets Summary
HUTCHMED (China) Ltd

Wall Street analysts forecast HCM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HCM is 320.91 GBX with a low forecast of 206.79 GBX and a high forecast of 468.73 GBX.

Lowest
Price Target
206.79 GBX
7% Upside
Average
Price Target
320.91 GBX
66% Upside
Highest
Price Target
468.73 GBX
143% Upside
HUTCHMED (China) Ltd Competitors:
Price Targets
002653
Haisco Pharmaceutical Group Co Ltd
75% Upside
LOVE
Cannara Biotech Inc
110% Upside
FAE
Faes Farma SA
5% Upside
1093
CSPC Pharmaceutical Group Ltd
16% Upside
RPRX
Royalty Pharma PLC
18% Upside

Revenue
Forecast

Revenue Estimate
HUTCHMED (China) Ltd

For the last 13 years the compound annual growth rate for HUTCHMED (China) Ltd's revenue is 11%. The projected CAGR for the next 4 years is 14%.

11%
Past Growth
14%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
HUTCHMED (China) Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
HUTCHMED (China) Ltd

For the last 13 years the compound annual growth rate for HUTCHMED (China) Ltd's net income is 36%. The projected CAGR for the next 4 years is 0%.

36%
Past Growth
0%
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HCM's stock price target?
Price Target
320.91 GBX

According to Wall Street analysts, the average 1-year price target for HCM is 320.91 GBX with a low forecast of 206.79 GBX and a high forecast of 468.73 GBX.

What is HUTCHMED (China) Ltd's Revenue forecast?
Projected CAGR
14%

For the last 13 years the compound annual growth rate for HUTCHMED (China) Ltd's revenue is 11%. The projected CAGR for the next 4 years is 14%.

What is HUTCHMED (China) Ltd's Net Income forecast?
Projected CAGR
0%

For the last 13 years the compound annual growth rate for HUTCHMED (China) Ltd's net income is 36%. The projected CAGR for the next 4 years is 0%.

Back to Top